Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Manufacturers Notice of Registration - 2007 > Boehringer Ingelheim Chemicals Inc.

Manufacturers Notice of Registration - 2007

FR Doc E7-3296 [Federal Register: February 27, 2007 (Volume 72, Number 38)] [Notices] [Page 8792] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr27fe07-128]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated October 6, 2006, and published in the Federal Register on October 18, 2006, (71 FR 61510), Boehringer Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:

Drug  Schedule
Tetrahydrocannabinols (7370)  I
Amphetamine (1100)  II
Methylphenidate (1724)  II
Methadone (9250)  II
Methadone Intermediate (9254)  II
Dextropropoxyphene, bulk (non-dosage forms) (9273)  II
Fentanyl(9801)  II

The company plans to manufacture the listed controlled substances in bulk for sale to its customers for formulation into finished pharmaceuticals.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Boehringer Ingelheim Chemicals Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Boehringer Ingelheim Chemicals Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: February 16, 2007.

Joseph T. Rannazzisi, 
Deputy Assistant Administrator, Office of Diversion Control Drug Enforcement, Administration.

[FR Doc. E7-3296 Filed 2-26-07; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility